Label: SALICYLIC ACID liquid

  • NDC Code(s): 42192-135-10
  • Packager: Acella Pharmaceuticals, LLC
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated January 11, 2024

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Wart Remover

    Rx Only

    FOR TOPICAL USE ONLY. NOT FOR OPHTHALMIC, ORAL OR INTRAVAGINAL USE.

  • DESCRIPTION:

    Salicylic Acid, 27.5% Wart Remover is a topical preparation containing 27.5% salicylic acid in a film-forming vehicle composed of isopropyl alcohol, isobutyrate, acrylates copolymer, N butyl acetate and polyvinyl butyrate. The pharmacologic activity of Salicylic Acid, 27.5% Wart Remover is generally attributed to the keratolytic activity of salicylic acid which is incorporated into a film-forming vehicle designed to cover the wart without the need for a bandage. The structural formula of salicylic acid is:

    mm1

  • CLINICAL PHARMACOLOGY:

    Although the exact mode of action for salicylic acid in the treatment of warts is not known, its activity appears to be associated with its keratolytic action which results in mechanical removal of epidermal cells infected with wart viruses.

  • INDICATIONS AND USES:

    Salicylic Acid, 27.5% Wart Remover is indicated for the topical treatment and removal of common warts and plantar warts.

  • CONTRAINDICATIONS:

    Salicylic Acid, 27.5% Wart Remover should not be used by diabetics or patients with impaired blood circulation. Salicylic Acid, 27.5% Wart Remover should not be used on moles, birthmarks, unusual warts with hair growing from them or warts on the face.

  • PRECAUTIONS:

    Salicylic Acid, 27.5% Wart Remover is for external use only. Do not permit Salicylic Acid, 27.5% Wart Remover to contact eyes or mucous membranes. If contact with eyes or mucous membranes occurs, immediately flush with water for 15 minutes. Salicylic Acid, 27.5% Wart Remover should not be allowed to contact normal skin surrounding wart. Treatment should be discontinued if excessive irritation occurs. Salicylic Acid, 27.5% Wart Remover is flammable and should be kept away from fire or flame. Keep bottle tightly capped when not in use.

    KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

  • ADVERSE REACTIONS:

    A localized irritant reaction may occur if Salicylic Acid, 27.5% Wart Remover is applied to the normal skin surrounding the wart. Any irritation may normally be controlled by temporarily discontinuing use and by applying the medication only to the wart site when treatment is resumed.

  • DOSAGE AND ADMINISTRATION:

    Prior to application of Salicylic Acid, 27.5% Wart Remover, soak wart in warm water for five minutes. Remove any loosened tissue by gently rubbing with a brush, wash cloth or emery board. Dry thoroughly. Using the brush applicator supplied, apply twice to entire wart surface, allowing the first application to dry before applying the second. Treatment should be once or twice a day and should continue as directed by physician. Be careful not to apply to surrounding skin.

    Clinically visible improvement will normally occur during the first or second week of therapy. Maximum resolution may be expected after four to six weeks of use.

  • HOW SUPPLIED:

    Salicylic Acid, 27.5% Wart Remover is supplied in 10 mL amber bottles with a brush applicator, (NDC 42192-135-10).

  • STORAGE AND HANDLING

    Store at controlled room temperature, 15º - 30º (59º - 86ºF).

    MANUFACTURED FOR:
    Acella Pharmaceuticals, LLC
    Alpharetta, GA 30009
    1-800-541-4802
    Rev. 0611

  • PATIENT INSTRUCTIONS:

    Your health care provider has prescribed Salicylic Acid, 27.5% Wart Remover, a topical prescription preparation for the treatment of common and plantar warts. In order for Salicylic Acid, 27.5% Wart Remover to work correctly and to ensure maximum benefit, the following instructions should be followed carefully. Of course, as with any medication, always consult your health care provider if you experience any discomfort or unexpected reactions.

  • STEP 1: WASH

    • Soak wart area in warm water for about 5 minutes.
    • Remove any loose tissue using a wash cloth, emery board or pumice stone.
    • Dry thoroughly.
  • STEP 2: BRUSH

    • Using the brush applicator supplied, apply twice to entire wart surface, allowing the first application to dry before applying the second.
    • Be careful not to apply to surrounding skin.
    • Leave Salicylic Acid, 27.5% Wart Remover on wart area after it dries.

    Repeat Step 1 and Step 2 once or twice daily as advised by your health care provider.

    Clinically visible improvement will normally occur during the first or second week of therapy.

    MANUFACTURED FOR:
    Acella Pharmaceuticals, LLC
    Alpharetta, GA 30009
    1-800-541-4802

    Rev. 0611

  • PRINCIPAL DISPLAY PANEL - 10 mL

    NDC 42192-135-10

    Salicylic
    Acid, 27.5%
    WART REMOVER

    Film-Forming Vehicle

    Rx Only

    FOR DERMATOLOGICAL USE
    ONLY.
    NOT FOR USE IN EYES.

    1/3 fl. oz. (10 mL)

    Acella
    PHARMACEUTICALS, LLC.

    image of carton

  • INGREDIENTS AND APPEARANCE
    SALICYLIC ACID 
    salicylic acid liquid
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:42192-135
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID275 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    ISOPROPYL ALCOHOL (UNII: ND2M416302)  
    BUTYL ACETATE (UNII: 464P5N1905)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:42192-135-101 in 1 CARTON10/10/2011
    110 mL in 1 BOTTLE, WITH APPLICATOR; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other10/10/2011
    Labeler - Acella Pharmaceuticals, LLC (825380939)
    Registrant - Acella Pharmaceuticals, LLC (825380939)
    Establishment
    NameAddressID/FEIBusiness Operations
    Acella Pharmaceuticals, LLC825380939manufacture(42192-135)